PAS
WST icon

Park Avenue Securities’s West Pharmaceutical WST Stock Holding History

Park Avenue Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
+4,381
New +$1.34M 0.01% 773
2026
Q1 		– Sell
-9,724
Closed -$2.68M – 1723
2025
Q4 		$2.68M Sell
9,724
-188
-2% -$51.4K 0.02% 447
2025
Q3 		$2.6M Sell
9,912
-973
-9% -$236K 0.02% 491
2025
Q2 		$2.38M Sell
10,885
-272
-2% -$58.1K 0.02% 462
2025
Q1 		$2.5M Buy
11,157
+2,440
+28% +$672K 0.03% 344
2024
Q4 		$2.85M Buy
8,717
+1,222
+16% +$385K 0.03% 362
2024
Q3 		$2.25M Sell
7,495
-654
-8% -$200K 0.03% 402
2024
Q2 		$2.68M Buy
8,149
+466
+6% +$165K 0.03% 334
2024
Q1 		$3.04M Buy
7,683
+291
+4% +$108K 0.04% 293
2023
Q4 		$2.6M Sell
7,392
-154
-2% -$54.5K 0.04% 305
2023
Q3 		$2.83M Buy
+7,546
New +$2.92M 0.04% 247
2023
Q1 		– Sell
-7,739
Closed -$1.82M – 1173
2022
Q4 		$1.82M Sell
7,739
-1,085
-12% -$257K 0.03% 333
2022
Q3 		$2.17M Sell
8,824
-1,500
-15% -$457K 0.04% 249
2022
Q2 		$3.12M Sell
10,324
-900
-8% -$293K 0.06% 192
2022
Q1 		$4.61M Buy
11,224
+548
+5% +$215K 0.08% 136
2021
Q4 		$5.01M Buy
10,676
+1,085
+11% +$467K 0.09% 126
2021
Q3 		$4.07M Sell
9,591
-323
-3% -$136K 0.08% 122
2021
Q2 		$3.56M Buy
9,914
+1,865
+23% +$616K 0.08% 138
2021
Q1 		$2.27M Buy
8,049
+1,457
+22% +$417K 0.06% 181
2020
Q4 		$1.87M Buy
6,592
+920
+16% +$258K 0.05% 167
2020
Q3 		$1.56M Buy
5,672
+863
+18% +$228K 0.05% 159
2020
Q2 		$1.09M Buy
+4,809
New +$945K 0.04% 182
2020
Q1 		– Sell
-2,622
Closed -$394K – 622
2019
Q4 		$394K Sell
2,622
-49
-2% -$7.13K 0.02% 394
2019
Q3 		$379K Buy
+2,671
New +$368K 0.02% 305
2019
Q2 		– Sell
-2,195
Closed -$245K – 485
2019
Q1 		$245K Buy
+2,195
New +$228K 0.01% 382

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Park Avenue Securities's WST Position: Q2 2026 in Review

Park Avenue Securities opened a new position in West Pharmaceutical (WST) in Q2 2026: 4,381 shares worth $1.57M. The stake represents 0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in WST as recently as Q4 2025.

Park Avenue Securities first reported a position in WST in Q1 2019 and has held it in 25 quarters since. The position peaked at $5.01M in Q4 2021. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Park Avenue Securities held 4,381 shares of West Pharmaceutical worth $1.57M as of Q2 2026.
  • West Pharmaceutical was a new Park Avenue Securities position in Q2 2026.
  • West Pharmaceutical made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #773 holding.
  • Park Avenue Securities first reported a position in West Pharmaceutical in Q1 2019 and has held it in 25 quarters since.
  • Park Avenue Securities's West Pharmaceutical position peaked at $5.01M in Q4 2021.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.